Compare VSAT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSAT | BAX |
|---|---|---|
| Founded | 1986 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | 1996 | 1994 |
| Metric | VSAT | BAX |
|---|---|---|
| Price | $68.76 | $17.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 9 |
| Target Price | ★ $59.80 | $21.00 |
| AVG Volume (30 Days) | 1.3M | ★ 7.3M |
| Earning Date | 05-19-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 50.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $5.32 | $1.96 |
| Revenue Next Year | $3.57 | $2.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $8.70 | $15.73 |
| 52 Week High | $68.92 | $32.68 |
| Indicator | VSAT | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 67.97 | 47.29 |
| Support Level | $42.18 | $15.95 |
| Resistance Level | N/A | $17.50 |
| Average True Range (ATR) | 3.13 | 0.73 |
| MACD | 0.22 | -0.07 |
| Stochastic Oscillator | 92.34 | 36.98 |
Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.